Current Neuropharmacology

Papers
(The H4-Index of Current Neuropharmacology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease124
Role of Glycerophospholipid Metabolism in Epilepsy98
The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review97
Childhood Trauma and Self-harm in Youths with Bipolar Disorders90
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome87
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring86
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study76
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction72
Mimicking Extracellular Matrix via Engineered Nanostructured Biomaterials for Neural Repair68
The Role of Natural Products in Treatment of Depressive Disorder67
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases65
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 201760
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management59
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats56
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS51
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential51
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder49
Meet the Editorial Board Member47
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)47
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study44
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis44
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics43
Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor43
Microglia-Astrocyte Crosstalk in Post-Stroke Neuroinflammation: Mechanisms and Therapeutic Strategies39
Effects of Deep Brain Stimulation on Sleep-Wake Disturbances in Patients with Parkinson's Disease: A Narrative Review39
OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression38
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation38
Myeloid-derived Suppressor Cells and Multiple Sclerosis37
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases35
Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach34
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials34
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy33
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase32
What is the Role of Lithium in Epilepsy?32
0.076033115386963